Every year, Science’s sister publication, the journal Science Translational Medicine chooses a select group of early-career translational scientists to serve as Associate Scientific Advisors. This year, another trainee of the CTSC’s Clinical and Translational Education Program (CTEP) has won this distinction: Bishoy M. Faltas, MD, is currently a research fellow at the Institute of Precision Medicine at Weill Cornell Medical College (WCMC). He is a CTSC trainee in the Clinical Research Methodology Curriculum (CRMC) course.
As advisors to the journal, the Associate Scientific Advisors will scan the literature weekly, selecting and summarizing research papers to be highlighted in the journal’s Editors’ Choice section. Each Associate Advisor will have approximately eight of their articles appear in Science Translational Medicine over the next year.
Dr. Faltas’ research is currently focused on the molecular profiling of metastatic platinum-resistant urothelial bladder carcinoma, a disease with no effective treatment options. He is conducting this research under the mentorship of Dr. Mark Rubin, MD, director of Weill Cornell’s Institute of Precision Medicine. One of his ultimate goals is to identify the driver mutations for metastatic urothelial carcinoma and to identify potential drug targets so that these findings may translate into therapeutic clinical trials.
Dr. Faltas is the sixth CTSC trainee chosen for this honor. Previous CTSC honorees include:
- Richard Lin, MD, PhD (Assistant Professor of Medicine, Hospital Medicine, at WCMC and recipient of the Advanced Certificate in Clinical and Translational Investigation)
- Elaine Cheng, MD, MS (Abdominal Transplant Surgery Fellow at UCLA, former Surgery Fellow at WCMC, and CTSC KL2 Scholar Award Alumna)
- Margaret Callahan, MD, PhD (Assistant Attending, Department of Medicine at Memorial Sloan-Kettering Cancer Center [MSKCC], and alumna of the CTSC CRMC program)
- Alexei Morozov, MD, PhD (Senior Medical Director, Clinical Program Leader, Novartis, and former Clinical Fellow, Oncology, at MSKCC while a CTSC KL2 Scholar)
- Kenneth Ng, PhD, MS (Medical Director at Health Science Communications, NYC; CTSC TL1 Training Award Alumnus; and former Post-doc Fellow, Orthopaedics, Hospital for Special Surgery)
Dr. Faltas’ first article, a précis of Nord et al.’s 2014 report in Nature Genetics, has just been published (Faltas BM. The GRM face of chondromyoxoid fibroma. Sci Transl Med 9 April 2014 6:231ec62. [DOI:10.1126/scitranslmed.3009044]).
Please join us in congratulating Dr. Faltas on this wonderful accomplishment.